Russnes Hege G, Lønning Per E, Børresen-Dale Anne-Lise, Lingjærde Ole C
Genome Biol. 2014;15(9):447. doi: 10.1186/s13059-014-0447-6.
The availability of large amounts of molecular data of unprecedented depth and width has instigated new paths of interdisciplinary activity in cancer research. Translation of such information to allow its optimal use in cancer therapy will require molecular biologists to embrace statistical and computational concepts and models. Progress in science has been and should be driven by our innate curiosity. This is the human quality that led Pandora to open the forbidden box, and like her, we do not know the nature or consequences of the output resulting from our actions. Throughout history, ground-breaking scientific achievements have been closely linked to advances in technology. The microscope and the telescope are examples of inventions that profoundly increased the amount of observable features that further led to paradigmatic shifts in our understanding of life and the Universe. In cell biology, the microscope revealed details of different types of tissue and their cellular composition; it revealed cells, their structures and their ability to divide, develop and die. Further, the molecular compositions of individual cell types were revealed gradually by generations of scientists. For each level of insight gained, new mathematical and statistical descriptive and analytical tools were needed (Figure 1a). The integration of knowledge of ever-increasing depth and width in order to develop useful therapies that can prevent and cure diseases such as cancer will continue to require the joint effort of scientists in biology, medicine, statistics, mathematics and computation. Here, we discuss some major challenges that lie ahead of us and why we believe that a deeper integration of biology and medicine with mathematics and statistics is required to gain the most from the diverse and extensive body of data now being generated. We also argue that to take full advantage of current technological opportunities, we must explore biomarkers using clinical studies that are optimally designed for this purpose. The need for a tight interdisciplinary collaboration has never been stronger.
大量具有前所未有的深度和广度的分子数据的可得性,推动了癌症研究中跨学科活动的新路径。要将此类信息转化以便在癌症治疗中得到最佳利用,分子生物学家需要接受统计学和计算概念及模型。科学的进步一直且应该由我们与生俱来的好奇心驱动。正是这种人类特质促使潘多拉打开了那个禁忌之盒,而和她一样,我们并不知晓我们行动所产生结果的本质或后果。纵观历史,开创性的科学成就一直与技术进步紧密相连。显微镜和望远镜就是这样的发明实例,它们极大地增加了可观测特征的数量,进而导致我们对生命和宇宙的理解发生了范式转变。在细胞生物学中,显微镜揭示了不同类型组织及其细胞组成的细节;它揭示了细胞、它们的结构以及它们分裂、发育和死亡的能力。此外,一代又一代的科学家逐渐揭示了各个细胞类型的分子组成。对于所获得的每一个深入层面的见解,都需要新的数学和统计描述及分析工具(图1a)。为了开发出能够预防和治愈诸如癌症等疾病的有效疗法,整合不断增加的深度和广度的知识将继续需要生物学、医学及统计学、数学和计算领域的科学家共同努力。在此,我们讨论一些摆在我们面前的主要挑战,以及为什么我们认为生物学和医学与数学和统计学进行更深入的整合对于充分利用目前正在生成的多样且广泛的数据至关重要。我们还认为,为了充分利用当前的技术机遇,可以通过为此目的进行优化设计的临床研究来探索生物标志物。紧密的跨学科合作的必要性从未如此强烈。